Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPeriPharm
About this trial
This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.
Eligibility criteria
Qualifiers
Aged ≥18 years;
Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis;
Able to read and understand French or English;
Willing and able to provide written informed consent.
Disqualifiers
Caregivers whose child has been diagnosed with severe atopic dermatitis ;
Caregivers whose child is currently treated with oral or topical Janus Kinase Inhibitor);
Caregivers whose child is currently participating in a clinical trial for atopic dermatitis;
Other parent or caregiver within the household of the child with atopic dermatitis.
Trial design
Treatments tested in this trial
- No Intervention: Observational Cohort
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov